Trending Content - Investment Banking Forum
| +355 | Evercore Intern Seizure | 54 | 7h |
| +67 | JPM M&A is Gone??? Purely Coverage Banking??? | 31 | 6h |
| +58 | Is DCM actually underrated ? | 24 | 17h |
| +50 | How do I understand vs. just memorizing? | 5 | 16h |
| +48 | Losing my personality in Banking | 9 | 17h |
| +47 | Are all Tech / TMT groups sweaty? | 38 | 13h |
| +42 | Associate & Above IB exits | 16 | 3d |
| +32 | Incoming IB Analyst: Best Ways to Prepare? | 10 | 9h |
| +27 | Which groups are ideal for laterals? | 12 | 11h |
| +24 | The good and bad with Wells Fargo | 1 | 17h |
Career Resources
Not sure about t5 but ik PWP kills it in medtech
yea have heard the same about PWP HC
JPM for BBs and CVP for EBs (pharma / biotech). Gugg is the best medtech group.
JPM, EVR, CVP and MS are all very strong
not exhaustive, but Goldman, Centerview, Evercore, JPM, Guggenheim are all top performers In HC generally
I’d at Moelis and Perella, easy
CVP/Gugg > Moelis.
Toss up between JPM/MS/GS for BBs. They’re pretty dominant across all verticals and products (JPM obviously dominant on debt though). I would say these three are the best in HC by a pretty large margin and touch most large cap transactions. I think equity capabilities are pretty important in HC, and JPM/GS/MS are by far the best.
As far as EBs go, CVP is the best. They kill it in pharma. Evercore and Lazard are also good.
Exercitationem fugiat similique et qui dolorum nostrum. Saepe quae autem mollitia et. Earum praesentium consectetur at aliquid beatae expedita neque. Eos aut iusto nulla officiis impedit. Minus blanditiis omnis sed aliquam dolores.
Quo minus in voluptatibus vel vel sed. Sunt error eaque dolor quam ut magni.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...